Lv1
60 积分 2023-09-17 加入
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC)
3个月前
已关闭
Effects of neutral sphingomyelinase activation associated factor (Nsmaf) gene knock‐down on myogenesis in murine C2C12 myoblast
3个月前
已关闭
Role of Radiotherapy in the Treatment of Renal Cell Cancer: Updated and Critical Review
3个月前
已完结
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment
3个月前
已完结
Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials
3个月前
已完结
Phase II clinical study of the safety and efficacy of sintilimab in combination with axitinib and stereotactic radiotherapy in the treatment of local-regional recurrent renal cell cancer
4个月前
已完结
Phase II clinical study of the safety and efficacy of sintilimab in combination with axitinib and stereotactic radiotherapy in the treatment of local-regional recurrent renal cell cancer
4个月前
已完结
A phase Ib study of safety and preliminary efficacy of extracranial stereotactic body radiation therapy (SBRT) in patients with metastatic renal cell carcinoma (mRCC) treated with systemic therapy
5个月前
已完结
Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months
5个月前
已关闭
50: Prospective Neurocognitive Functions of Patients Treated with Concurrent Nivolumab and Stereotactic Brain Radiosurgery for NSCLC and RCC Brain Metastases
5个月前
已完结
皖公网安备34019202002308
